---
figid: PMC6996551__CMAR-12-675-g0001
figtitle: Cyclin D1–CDK4/6–RB and PI3K/AKT/mTOR pathways in BC
organisms:
- Homo sapiens
- Mouse mammary tumor virus
pmcid: PMC6996551
filename: CMAR-12-675-g0001.jpg
figlink: pmc/articles/PMC6996551/figure/F0001/
number: F1
caption: 'The role of cyclin D1–CDK4/6–RB and PI3K/AKT/mTOR pathways in BC. ER transcriptional
  activity and signaling through HER2/PI3K/AKT/mTOR increase cyclin D1 levels, activating
  CDK4/6 and promoting cellular progression to the S phase. Combined inhibition of
  CDK4/6 and nodes in the PI3K pathway can suppress mTORC1 activity as well as RB
  phosphorylation, inhibiting two promoters of S phase progression.Abbreviations:
  EGFR, epidermal growth factor receptor; ER, estrogen receptor; HER, human epidermal
  growth factor receptor; mTOR, mammalian target of rapamycin; PI3K, phosphoinositide-3-kinase;
  RB, retinoblastoma protein; TSC2, tuberous sclerosis complex 2.'
papertitle: 'Strategies for Increasing the Effectiveness of Aromatase Inhibitors in
  Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options.'
reftext: Giulia Grizzi, et al. Cancer Manag Res. 2020;12:675-686.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8957155
figid_alias: PMC6996551__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6996551__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6996551__CMAR-12-675-g0001.html
  '@type': Dataset
  description: 'The role of cyclin D1–CDK4/6–RB and PI3K/AKT/mTOR pathways in BC.
    ER transcriptional activity and signaling through HER2/PI3K/AKT/mTOR increase
    cyclin D1 levels, activating CDK4/6 and promoting cellular progression to the
    S phase. Combined inhibition of CDK4/6 and nodes in the PI3K pathway can suppress
    mTORC1 activity as well as RB phosphorylation, inhibiting two promoters of S phase
    progression.Abbreviations: EGFR, epidermal growth factor receptor; ER, estrogen
    receptor; HER, human epidermal growth factor receptor; mTOR, mammalian target
    of rapamycin; PI3K, phosphoinositide-3-kinase; RB, retinoblastoma protein; TSC2,
    tuberous sclerosis complex 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - ERBB3
  - EGFR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TSC2
  - MTOR
  - RPTOR
  - CCND1
  - CDK4
  - CDK6
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - lapatinib
  - neratinib
  - letrozole
  - anastrozole
  - exemestane
  - Estradiol
  - buparlisib
  - tamoxifen
  - everolimus
---
